Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1630 (LINC01630)
- Target
- LINC01630
- Molecular classification
- Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA), Other
01
Overview
Long intergenic non-protein coding RNA 1630 (LINC01630) is a member of the long non-coding RNA family that is classified as a long intergenic non-coding RNA (lincRNA)[1][5]. LincRNAs are defined as autonomously transcribed non-coding RNAs longer than 200 nucleotides, located in genomic regions that do not overlap with coding genes[3][9][5]. LincRNAs, including LINC01630, generally do not encode proteins, but may exert important functions in the regulation of gene expression, chromatin remodeling, and genome architecture through various mechanisms[3][9]. The exact biological and clinical significance of LINC01630 remains to be fully elucidated, and there are no current therapeutic interventions or biomarkers associated specifically with this RNA[1][5]. Its best-described roles are inferred from the broader study of lincRNAs, which are increasingly recognized as key players in gene regulatory networks[3][9].
- Other names
- LINC01630LOC100287225
02
Biological functions
Regulation of gene expression (transcriptional and post-transcriptional regulation)RNA stabilizationPossible roles in chromatin remodeling and genome architectureEnhancement or repression of transcription via enhancer-like functions
03
Disease associations
Other (As of current knowledge, there is no specific, well-established disease association for LINC01630; some lincRNAs in general have been implicated in cancer and other diseases, but LINC01630's precise involvement remains inadequately established in the literature[1][5].)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1630 (LINC01630).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1630 (LINC01630).